Selinexor for the Treatment of Intermediate and High-Risk Smoldering Multiple Myeloma
Clinical trial NCT05597345 · RECRUITING
Trial details
- NCT number
- NCT05597345
- Sponsor
- University of Rochester
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-21
- Primary completion
- 2024-10-29
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.